Industry News
Ferrer announces first patient enrollment of FNP122 in ADORE Phase III trial for ALS treatment
The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)
The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)